Dulaglutide is a highly efficacious treatment for hyperglycemia in T2D that was developed based on incretin physiology, as GLP-1 is released after nutrient ingestion and stimulates glucose-dependent secretion of insulin. The gene discussed is GCG; the disease is type 2 diabetes mellitus.